New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine
The FDA has approved a new type of influenza vaccine developed by Moderna using mRNA technology, targeting older populations. The approval marks an advancement in flu vaccination methods.
AI-generated summary
Read this story on The Seattle Times